<DOC>
	<DOC>NCT01020474</DOC>
	<brief_summary>This study will compare pregabalin with placebo over a 15 week period in adolescents with fibromyalgia aged 12-17 years to evaluate the safety and efficacy of pregabalin.</brief_summary>
	<brief_title>Adolescent Fibromyalgia Study</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Diagnosis of fibromyalgia 1217 years of age Patients with other pain conditions Previous treatment with pregabalin Patients taking excluded medication</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>juvenile primary fibromyalgia syndrome</keyword>
	<keyword>pediatric fibromyalgia</keyword>
	<keyword>pregabalin</keyword>
	<keyword>and Lyrica</keyword>
</DOC>